The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method
The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method
复制标题
使用电子健康数据制定系统性红斑狼疮质量指标：改进的 RAND 适当性方法
DOI：
10.1080/14397595.2019.1621419
复制
发表时间：
2019
影响因子：
2.2
通讯作者：
et al.
中科院分区：
文献类型：
--
作者：
Yajima Nobuyuki;Tsujimoto Yasushi;Fukuma Shingo;Sada Ken-ei;Shimizu Sayaka;Niihata Kakuya;Takahashi Ryo;Asano Yoshihide;Azuma Teruhisa;Kameda Hideto;Kuwana Masataka;Kohsaka Hitoshi;Sugiura-Ogasawara Mayumi;et al.
目的：质量指标（QIs）是标准化评估最低可接受的护理质量的工具，可能有助于更好地管理系统性红斑狼疮（SLE）患者。本研究的目的是利用电子健康数据建立SLE的QIs。方法：采用改良的兰德/UCLA适当方法建立QIs。首先，进行了文献综述。其次，提取可用于使用电子健康数据进行评估的候选QI项目。第三，通过评分轮和小组成员的讨论来评估条目的适当性。结果：在初始搜索中，我们发现了3621篇文章。最后，34项研究进行了审查，其中17个潜在的指标被提取为候选QIs。通过适当性过程，选择了12个指标作为最终的QI。这12个指标的适当性中位数至少为7.5，所有指标都没有异议。QI包括疾病活动性评估、SLE治疗、药物毒性监测、糖皮质激素并发症治疗和SLE并发症评估。结论：我们根据电子医疗数据制定了12个用于评估SLE患者的QI。我们的QI集将是一个实用的工具，作为一个质量措施。
Objective:Quality indicators (QIs) are tools that standardize evaluations in terms of the minimum acceptable quality of care, presumably contributing for the better management of patients with systemic lupus erythematosus (SLE). This study aimed to develop QIs for SLE using electronic health data.Methods:The modified RAND/UCLA Appropriateness Method was used to develop the QIs. First, a literature review was conducted. Second, the candidate QI items that were available to be evaluated using the electronic health data were extracted. Third, the appropriateness of the items was assessed via rating rounds and panelists’ discussions.Results:We found 3621 articles in the initial search. Finally, 34 studies were reviewed, from which 17 potential indicators were extracted as candidate QIs. Twelve indicators were selected as the final QI set through the process of appropriateness. The median appropriateness of these 12 indicators was at least 7.5, and all of them were without disagreement. The QI included assessment of disease activity, treatment of SLE, drug toxicity monitoring, treatment of glucocorticoid complications, and assessment of SLE complications.Conclusion:We formulated 12 QIs for the assessment of patients with SLE based on electronic medical data. Our QI set would be a practical tool as a quality measure.